Teva Pharmaceutical Indus... (TEVA)
| Bid | 16.16 |
| Market Cap | 18.53B |
| Revenue (ttm) | 16.73B |
| Net Income (ttm) | -1.66B |
| EPS (ttm) | -1.45 |
| PE Ratio (ttm) | -11.16 |
| Forward PE | 6.55 |
| Analyst | Buy |
| Ask | 16.21 |
| Volume | 7,306,505 |
| Avg. Volume (20D) | 12,264,958 |
| Open | 15.94 |
| Previous Close | 16.10 |
| Day's Range | 15.94 - 16.28 |
| 52-Week Range | 12.51 - 22.80 |
| Beta | 0.83 |
About TEVA
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and cr...
Analyst Forecast
According to 6 analyst ratings, the average rating for TEVA stock is "Buy." The 12-month stock price forecast is $24.5, which is an increase of 51.47% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago · seekingalpha.com
Teva: Branded Momentum Clashes With Generic Declines And IRA HeadwindsTeva's Q4 earnings reveal significant headwinds, including declining U.S. generics revenue and rising costs in the API business, impacting overall profitability. Branded drugs like Austedo and Uzedy f...
1 month ago · youtube.com
Final Trade: TEVA, JNJ, TJX, BABAThe final trades of the day with the Fast Money traders.
